December 20, 2023

Know Labs

Seattle-based Know Labs, a developer of non-invasive medical diagnostic technology, appointed four new members to its medical and scientific advisory board: Jeff Hitchcock, Karmeen Kulkarni, Dr. Meng Tan and Dr. Satish Garg. They bring extensive experience in clinical diabetes management, including the advancement of new technologies and innovation in medical diagnostics. The board provides guidance to the executive team and board of directors as the company moves from the laboratory to clinical testing and FDA clearance of its non-invasive continuous glucose monitor. Hitchcock is the founder, president and CEO of Children with Diabetes (CWD), an honorary member of the International Society for Pediatric and Adolescent Diabetes, and a recipient of the T1D Exchange 2021 Outstanding Parent Advisor Award. Hitchcock founded CWD in 1995 in response to his then 7-year-old daughter's T1D diagnosis in 1989. CWD provides families and caregivers with guidance through science-based content and practical suggestions from pediatric endocrinologists, certified diabetes educators, nurses, nutritionists, researchers, advocates and fellow parents. Kulkarni is a certified diabetes care and education specialist, board-certified advanced diabetes manager and registered dietitian. Recognized for her clinical expertise and contributions to nutrition and diabetes management, Kulkarni has received numerous national awards from the American Dietetic Association, American Diabetes Association and Abbott Diabetes Care. Tan is currently professor emeritus of internal medicine for the Division of Metabolism, Endocrinology and Diabetes at the University of Michigan. Tan graduated with his M.D. from Dalhousie University, Halifax, Canada, and completed his post-doctoral training in diabetes at the Joslin Diabetes Center, Harvard University, and in lipoprotein metabolism at the Cardiovascular Research Institute, University of California, San Francisco. Garg is a professor of medicine and pediatrics at the Adult Clinic of the Barbara Davis Center for Diabetes at the University of Colorado School of Medicine. Garg has published over 350 original manuscripts in peer-reviewed journals, and has been part of several studies that have brought technological breakthroughs to diabetes care.